Diaphragm Thickness by Ultrasonography in Neurological Disorders
Assessment of Diaphragm Thickness by Ultrasonography in Guillain Barre Syndrome and Myasthenia Gravis
1 other identifier
interventional
60
1 country
1
Brief Summary
participants will be allocated into three groups, acute neuropathy (Guillain Barre Syndrome) group, neuromuscular junction disorder(myasthenia gravis ) group, and control group(people with neurological disorders not affecting the respiratory system.Ultrasonography is done on the diaphragm. The index test (ultrasound imaging of the diaphragm) is used. A high-resolution portable ultrasound machine is used, with a 7- to 13-MHz linear array transducer. Patients will be examined in the supine position. diaphragmatic thickness will is measured on both sides during a deep breath in inspiration and during expiration. objectives: primary outcome: to compare diaphragm thickness between the three examined groups. Secondary outcome: correlation between clinical scores and reference US values of diaphragm
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 4, 2022
CompletedFirst Posted
Study publicly available on registry
April 12, 2022
CompletedStudy Start
First participant enrolled
April 13, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 9, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
May 13, 2022
CompletedMay 16, 2022
May 1, 2022
26 days
April 4, 2022
May 13, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
diaphragm thickness
will be reported in (mm)
within 24 hours from hospital admission
Secondary Outcomes (1)
Hughes clinical score
within 24 hours from hospital admission
Study Arms (3)
Gillian-Barre
ACTIVE COMPARATORPatients will be examined in the supine position. diaphragmatic thickness will is measured on both sides during a deep breath in inspiration and during expiration.
Myasthenia Gravis
ACTIVE COMPARATORPatients will be examined in the supine position. diaphragmatic thickness will is measured on both sides during a deep breath in inspiration and during expiration.
control
ACTIVE COMPARATORPatients hospitalized with neurological disorders without affection of the respiratory system.
Interventions
diaphragmatic thickness will be measured on both sides during a deep breath in inspiration and during expiration.
Eligibility Criteria
You may qualify if:
- all adult patients admitted to the neurology department
You may not qualify if:
- cardiopulmonary diseases
- chest trauma
- diaphragmatic diseases
- Body Mass Index (BMI) \> 30
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Mansoura University Hospitals
Al Mansurah, Not in US Or Canada, 35516, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Aya M Zhran
Mansoura University Faculty of Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 4, 2022
First Posted
April 12, 2022
Study Start
April 13, 2022
Primary Completion
May 9, 2022
Study Completion
May 13, 2022
Last Updated
May 16, 2022
Record last verified: 2022-05
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- will be reported
- Access Criteria
- will be reported
Anonymous patients' data will be available with the PI or corresponding Author on reasonable request according to local IRB regulations